Phase I, Randomized, Parallel Group, Placebo Control, Unicentric, Interventional Study to Assess the Effect of Expanded Human Allogeneic Adipose-derived Mesenchymal Adult Stem Cells on the Human Response to Lipopolysaccharyde in Human Volunteers

Trial Profile

Phase I, Randomized, Parallel Group, Placebo Control, Unicentric, Interventional Study to Assess the Effect of Expanded Human Allogeneic Adipose-derived Mesenchymal Adult Stem Cells on the Human Response to Lipopolysaccharyde in Human Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 28 May 2015

At a glance

  • Drugs Cx 611 (Primary)
  • Indications Sepsis
  • Focus Pharmacodynamics; Proof of concept
  • Acronyms CELLULA
  • Sponsors TiGenix
  • Most Recent Events

    • 28 May 2015 Results published in a TiGenix media release.
    • 28 May 2015 Results were published in a TiGenix media release.
    • 02 Apr 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top